Literature DB >> 16487864

Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.

Christopher J Boos, Gregory Y H Lip.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487864     DOI: 10.1016/j.jacc.2005.11.033

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  2 in total

1.  Recent advances in pharmacotherapy of atrial fibrillation.

Authors:  J Singh; J S Braich
Journal:  Indian J Pharmacol       Date:  2009-08       Impact factor: 1.200

2.  High sensitivity C-reactive protein: a predictor for recurrence of atrial fibrillation after successful cardioversion.

Authors:  Enrico Vizzardi; Savina Nodari; Gregoriana Zanini; Alessandra Manerba; Silvia Frattini; Alberto Madureri; Riccardo Raddino; Livio Dei Cas
Journal:  Intern Emerg Med       Date:  2009-03-14       Impact factor: 3.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.